ISO 18562-1:2024

Overview

ISO 18562-1:2024 provides a comprehensive framework for the biocompatibility evaluation of breathing gas pathways in medical devices used in healthcare settings. This standard is fundamental for manufacturers and regulatory bodies aiming to ensure the safety of respiratory equipment. The document outlines general principles governing biological evaluation of materials in gas pathways within a risk management process. It categorizes gas pathways based on the nature and duration of contact with the gas stream, prescribes methods for evaluating existing data and identifying gaps, and emphasizes a systematic approach to assessing biological safety.

ISO 18562-1:2024 plays a crucial role in minimizing risks associated with potentially hazardous substances released from gas pathway materials, ultimately safeguarding patient health during respiratory therapy and other medical applications.

Key Topics

• Biocompatibility Assessment: Establishes the foundations for evaluating whether materials that make up gas pathways are safe for use during routine operation, cleaning, disinfection, and sterilization.
• Risk Management Integration: Mandates the integration of biological evaluation into the broader medical device risk management process, ensuring systematic hazard identification and control.
• Categorization of Gas Pathways: Defines pathways based on exposure duration and the type of patient contact, aiding in tailored biocompatibility evaluation.
• Data Evaluation and Gap Analysis: Requires the review of relevant biological safety data and systematic identification of missing information essential for thorough risk analysis.
• Identification of Additional Data Needs: Supports decision-making around when further testing or data collection is needed to address identified hazards.
• Assessment and Risk Control: Focuses on controlling residual risk and performing benefit-risk analysis to ensure safe device performance during its expected lifetime.
• Addressed Devices: Includes ventilators, anaesthesia workstations, breathing systems, oxygen concentrators, nebulizers, humidifiers, filters, masks, resuscitators, respiratory monitors, and many other respiratory-related accessories.

Applications

ISO 18562-1:2024 is directly applicable to:

• Manufacturers of Medical Devices: Particularly those producing respiratory care devices, accessories, and components with gas pathways, ensuring their products comply with biocompatibility and safety requirements.
• Regulatory Authorities: Reference point for assessing the biological safety of gas pathways in the approval and post-market surveillance of medical devices.
• Healthcare Providers: Assures hospitals and clinics that respiratory equipment has undergone rigorous biocompatibility evaluation focused on patient safety.
• Quality and Risk Management Professionals: Provides a structured methodology for integrating biocompatibility assessment into risk management files and ongoing product lifecycle activities.
• Testing Laboratories: Lays the groundwork for planning and conducting relevant chemical and toxicological analysis of substances that could be emitted from gas pathways.

This standard is essential for a wide range of respiratory medical devices, including ventilators, masks, humidifiers, tubing, and even less obvious items such as the interiors of incubators and oxygen hoods, where inspired gases contact internal surfaces.

Related Standards

The ISO 18562-1:2024 standard is part of a broader family of documents supporting comprehensive breathing gas pathway assessment:

• ISO 18562-2:2024 – Tests for emissions of particulate matter from gas pathways.
• ISO 18562-3:2024 – Tests for emissions of volatile organic substances (VOS).
• ISO 18562-4:2024 – Tests for leachables in condensate.
• ISO 10993-1:2018 – Guidance for evaluating and testing the biocompatibility of direct contact medical device surfaces.
• ISO 10993-17:2023 – Toxicological risk assessment procedures for device constituents.
• ISO 14971:2019 – Risk management framework for medical devices.

Implementation of ISO 18562-1, together with its related standards, ensures respiratory medical devices maintain the highest level of patient safety and meet international regulatory requirements for biocompatibility of gas pathways.

Key SEO terms: ISO 18562-1:2024, biocompatibility evaluation, breathing gas pathways, respiratory medical devices, risk management, medical device safety, healthcare standards, particulate emissions, volatile organic substances, medical gas pathways.